Filing Details
- Accession Number:
- 0001209191-12-052295
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-08 16:21:39
- Reporting Period:
- 2012-11-07
- Filing Date:
- 2012-11-08
- Accepted Time:
- 2012-11-08 16:21:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1215126 | G Margaret Mcglynn | C/O Vertex Pharmaceuticals Incorporated 130 Waverly St. Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-11-07 | 1,000 | $45.50 | 1,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Open market purchases reported on this line occurred at a weighted average price of $45.50 (range $45.22 to $45.71).
- Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.